Get Premium Access

How to Maintain Velocity Without Sacrificing Quality

Interview with Qualio Founder and CEO Robert Fenton

Fast, good, or cheap — you can only pick two, so which will it be? It’s a common question, but it’s probably not one that’s best suited for the medtech and healthtech industries.

For many, quality is viewed as a hurdle, slowing a project’s velocity, but Robert Fenton founder and CEO at Qualio is determined to change that reality for companies developing life-saving products.

While working in drug development for some of the world’s largest pharmaceutical companies, including Pfizer and LEO Pharma, Robert observed how an organization moves an idea from bench science to proof of concept and beyond.

“What really struck me is that companies make a clinical promise: First, do no harm,” he says. “If you’re working on a medical device that’s going to diagnose or treat something really important, it must be safe, it must work effectively, and it must work consistently, which is, essentially, the promise of quality.”

Robert set out to develop a cloud-based quality management system that would help life sciences companies launch and scale their life-saving products without sacrificing quality or slowing down the multistage process.

In this episode of Medsider, Robert shares his predictions for the life sciences industry in 2022. He also discusses how Qualio can support (and not hinder) medtech and healthtech companies as they move through the complex process of taking a product from conception to the market.

Premium Members Only

You don't have access to this post, but if you become a premium member, you'll be able to see the whole thing, including many other exclusive benefits.

Become a Member

Already have an account? Sign in.

You May Like These Articles

Premium Content

How to Build a Delightful Experience for Your Customers

Interview with Somnee CEO Tim Rosa

Tim Rosa is the CEO of Somnee, a company developing wearables based on personalized neuroscience to improve sleep quality. In this interview, Tim shares insights on building and scaling successful brands based on real customer experiences, keeping messaging clear, and using brand strategy as a business foundation. He also shares why solid data and clinical evidence in OTC products are essential and how he generates value out of ongoing research.

Read Sample

Premium Content

Building Resilience Through Rejection

Interview with Transverse Medical CEO Eric Goslau

Eric Goslau is the co-founder and CEO of Transverse Medical and has a background rooted in commercialization. Transverse Medical is developing the Point Guard Cerebral Embolic Protection Device, designed to prevent strokes during cardiovascular procedures by protecting the brain from debris that can enter the bloodstream during these interventions. In this interview, Eric shares how his background in sales helps him manage all aspects of the company, how fundraising cycles have worked for him, and his philosophy when it comes to product development: the enemy of good is perfect.

Read Sample

Premium Content

Nothing Matters as Much as Execution and Iteration

Interview with Wyndly CEO Aakash Shah

Wyndly is a telehealth company that helps people overcome their allergies with personalized treatment plans that can be followed from home. In this interview, CEO Aakash Shah shares insights on simplifying healthcare access by meeting patients online and emphasizes the importance of learning by doing to accelerate personal and business growth. Aakash also talks about the power of storytelling when engaging customers and investors, and of how to leverage video-based social media to reach both consumers and decision-makers effectively.

Read Sample

Medsider Premium

Become a premium member and unlock access to exclusive Medsider benefits.

Unlock Full Access

Medsider Interviews

How to Build a Delightful Experience for Your Customers

Interview with Somnee CEO Tim Rosa

Medsider Mentors

Medsider Playbooks

Playbook

A Guide to Widespread Adoption in Medtech

In medtech, developing novel, impactful technology is often just the starting line. The real race begins when you try to integrate your solution into the often-resistant healthcare system – a hurdle that has tripped up countless promising companies. Here are the key strategies and lessons from five veterans in the medtech space on how to overcome this hurdle.